Who is sponsoring NCT03865264?

NCT03865264 is sponsored by Baylor Research Institute.

What drugs are being tested in NCT03865264?

Interventions in NCT03865264: Recovery Enhancement Program.

What condition does NCT03865264 study?

NCT03865264 studies Living Liver and Kidney Donors.

Is NCT03865264 still recruiting?

NCT03865264 is currently terminated. Last updated 27 January 2026.

Last reviewed 2026-01-27 · How we verify

NCT03865264

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Living Organ Donor Recovery Enhancement Program

Terminated NA Last updated 27 January 2026

What this trial tests

NA trial testing Recovery Enhancement Program in Living Liver and Kidney Donors in 21 participants. Terminated before completion.

Timeline

20 April 2017

Primary endpoint
22 January 2024

22 January 2024

Quick facts

Lead sponsor	Baylor Research Institute
Phase	NA
Status	Terminated
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	supportive care
Enrollment	21
Start date	20 April 2017
Primary completion	22 January 2024
Estimated completion	22 January 2024
Sites	1 location across United States

Drugs / interventions tested

Recovery Enhancement Program

Conditions studied

Living Liver and Kidney Donors — all drugs for Living Liver and Kidney Donors →

Sponsor

Baylor Research Institute

Who can join

18 and older, any sex, with Living Liver and Kidney Donors. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of the study is to test if using these living donor-specific pre-transplant resources would lead to a better and faster recovery post-transplant.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Baylor Research Institute trials

Trials by the same sponsor.

NCT07467720 — Study to Evaluate the Clinical Utility of Radiation Exposure Reduction: Multi-site Rampart Guardian Peripheral Trial · NA · not yet recruiting
NCT07547878 — Rapid and Simultaneous Initiation of Four Guideline-Directed CKD Therapies (RAPID-CKD) · Phase 4 · not yet recruiting
NCT07460583 — ProActive Athlete Heart Program: Proposal for Cardiac Risk Screening in Former High-Intensity Athletes · NA · not yet recruiting
NCT07096544 — CALM Study: Cardiomems Assisted Lvad Management · NA · not yet recruiting
NCT07220395 — eHealth Literacy Intervention for Spanish Speaking Older Adults in the US · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03865264 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Baylor Research Institute
Last refreshed: 27 January 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03865264.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing